Baxter Total Liabilities 2010-2025 | BAX
Baxter total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Baxter total liabilities for the quarter ending March 31, 2025 were $18.758B, a 5.3% decline year-over-year.
- Baxter total liabilities for 2024 were $18.758B, a 5.3% decline from 2023.
- Baxter total liabilities for 2023 were $19.808B, a 11.54% decline from 2022.
- Baxter total liabilities for 2022 were $22.392B, a 8.23% decline from 2021.
Baxter Annual Total Liabilities (Millions of US $) |
2024 |
$18,758 |
2023 |
$19,808 |
2022 |
$22,392 |
2021 |
$24,400 |
2020 |
$11,293 |
2019 |
$10,281 |
2018 |
$7,854 |
2017 |
$7,995 |
2016 |
$7,266 |
2015 |
$12,097 |
2014 |
$17,982 |
2013 |
$16,738 |
2012 |
$13,412 |
2011 |
$12,245 |
2010 |
$10,693 |
2009 |
$9,934 |
Baxter Quarterly Total Liabilities (Millions of US $) |
2024-12-31 |
$18,758 |
2024-09-30 |
$18,734 |
2024-06-30 |
$18,604 |
2024-03-31 |
$19,553 |
2023-12-31 |
$19,808 |
2023-09-30 |
$22,490 |
2023-06-30 |
$22,254 |
2023-03-31 |
$22,350 |
2022-12-31 |
$22,392 |
2022-09-30 |
$22,386 |
2022-06-30 |
$22,928 |
2022-03-31 |
$23,597 |
2021-12-31 |
$24,400 |
2021-09-30 |
$10,992 |
2021-06-30 |
$11,147 |
2021-03-31 |
$10,976 |
2020-12-31 |
$11,293 |
2020-09-30 |
$11,496 |
2020-06-30 |
$11,305 |
2020-03-31 |
$11,345 |
2019-12-31 |
$10,281 |
2019-09-30 |
$9,682 |
2019-06-30 |
$9,708 |
2019-03-31 |
$8,681 |
2018-12-31 |
$7,854 |
2018-09-30 |
$7,734 |
2018-06-30 |
$7,709 |
2018-03-31 |
$7,797 |
2017-12-31 |
$7,995 |
2017-09-30 |
$8,082 |
2017-06-30 |
$7,798 |
2017-03-31 |
$6,984 |
2016-12-31 |
$7,266 |
2016-09-30 |
$7,131 |
2016-06-30 |
$7,472 |
2016-03-31 |
$8,330 |
2015-12-31 |
$12,097 |
2015-09-30 |
$12,327 |
2015-06-30 |
$21,994 |
2015-03-31 |
$17,573 |
2014-12-31 |
$17,982 |
2014-09-30 |
$17,137 |
2014-06-30 |
$16,942 |
2014-03-31 |
$16,568 |
2013-12-31 |
$16,738 |
2013-09-30 |
$17,504 |
2013-06-30 |
$16,436 |
2013-03-31 |
$13,317 |
2012-12-31 |
$13,412 |
2012-09-30 |
$12,635 |
2012-06-30 |
$11,834 |
2012-03-31 |
$11,820 |
2011-12-31 |
$12,245 |
2011-09-30 |
$10,653 |
2011-06-30 |
$10,497 |
2011-03-31 |
$10,442 |
2010-12-31 |
$10,693 |
2010-09-30 |
$10,800 |
2010-06-30 |
$10,353 |
2010-03-31 |
$10,507 |
2009-12-31 |
$9,934 |
2009-09-30 |
$9,643 |
2009-06-30 |
$8,969 |
2009-03-31 |
$8,795 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$15.731B |
$10.636B |
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
|